UPDATE: H.C. Wainwright Downgrades Entasis Therapeutics (ETTX) to Neutral
Tweet Send to a Friend
(Updated - March 4, 2022 6:15 AM EST)
H.C. Wainwright analyst Ed Arce downgraded Entasis Therapeutics (NASDAQ: ETTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Ed Arce downgraded Entasis Therapeutics (NASDAQ: ETTX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
